Bills/H.R. 1406

Lung Cancer Screening and Prevention Act of 2025

Lung Cancer Screening and Prevention Act of 2025

In CommitteeHealthcareHouseHouse Bill · 119th Congress
Bill Progress · House
Introduced
Committee
Passed House
Passed Senate
Passed Both
Signed

Plain Language Summary

# Lung Cancer Screening and Prevention Act of 2025 - Summary **What the Bill Does:** This bill would expand Medicare coverage for lung cancer screening tests. Currently, Medicare only covers screening tests that are specifically recommended by the U.S. Preventive Services Task Force (an independent panel of medical experts). This bill would allow Medicare to cover additional screening tests approved by the FDA, even if the task force hasn't recommended them.

The Centers for Medicare & Medicaid Services would determine which tests qualify and how much to pay for them. **Who It Affects:** The bill primarily affects Medicare beneficiaries (Americans 65 and older, plus some younger people with disabilities) who could gain access to a broader range of lung cancer screening options. It also affects healthcare providers and medical device manufacturers who develop new screening technologies, as their products could potentially reach more patients. **Current Status:** The bill was introduced in the House of Representatives and is currently in committee, meaning it has not yet been voted on by the full House. The bill is sponsored by Rep. Vern Buchanan (R-FL).

CRS Official Summary

Lung Cancer Screening and Prevention Act of 2025This bill authorizes Medicare coverage of additional types of lung cancer screening tests that are approved by the Food and Drug Administration, regardless of whether they are recommended by the United States Preventive Services Task Force. The Centers for Medicare & Medicaid Services must set coverage and payment limits for such tests. (Currently, Medicare covers screening tests for the early detection of lung cancer if they are recommended by the task force.)

Advertisement

Latest Action

February 18, 2025

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Subjects

CancerCardiovascular and respiratory healthHealth care coverage and accessHealth promotion and preventive careMedical tests and diagnostic methodsMedicare

Sponsor

8 cosponsors

Key Dates

Introduced
February 18, 2025
Last Updated
February 18, 2025
Read Full Text on Congress.gov →
Advertisement